017180.KS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 09:30):

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally...

Stats
Dzisiejszy wolumen	23 309.00
Średni wolumen	66 342.00
Kapitalizacja rynkowa	69.40B
EPS	KRW0 ( 2023-11-14 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW2.65 (0.13%)

Wolumen Korelacja

Długi: 0.01 (neutral)

Krótki: 1.00 (very strong)

Signal:(58.929) Expect same movement, but be aware

MYUNGMOON Pharm co.,Ltd Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MYUNGMOON Pharm co.,Ltd Korelacja - Waluta/Towar

0.07
( neutral )

0.08
( neutral )

0.43
( neutral )

-0.02
( neutral )

-0.15
( neutral )

0.65
( weak )

MYUNGMOON Pharm co.,Ltd Finanse

Annual	2023
Przychody:	KRW169.57B
Zysk brutto:	KRW94.52B (55.74 %)
EPS:	KRW-134.35

FY	2023
Przychody:	KRW169.57B
Zysk brutto:	KRW94.52B (55.74 %)
EPS:	KRW-134.35

FY	2022
Przychody:	KRW152.13B
Zysk brutto:	KRW78.10B (51.34 %)
EPS:	KRW232.74

FY	2021
Przychody:	KRW144.76B
Zysk brutto:	KRW62.34B (43.06 %)
EPS:	KRW0

Financial Reports:

No articles found.

MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, fillers, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, oral disease products, antidiarrheal agents, digestive system products, cold drugs, calcium products, nasal sprays, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.